LifeVantage Corporation Reports Preliminary Q2 Fiscal 2025 Results and Raises Revenue Guidance

Lehi, Utah – LifeVantage Corporation (Nasdaq: LFVN), a leader in health and wellness products designed to optimize cellular health, has announced its preliminary revenue results for the second quarter of fiscal 2025, ending December 31, 2024. The company also raised its revenue guidance for fiscal 2025, reflecting significant growth momentum.


Preliminary Q2 Fiscal 2025 Highlights

  1. Revenue Growth
    • $67.5 million, marking a 31% increase compared to the prior year and a 43% sequential rise from Q1 fiscal 2025.
  2. Active Account Growth
    • Americas: Up 22.7% year-over-year and 25.4% sequentially.
    • Global: Increased 12.1% year-over-year and 18.5% sequentially.

Updated Fiscal 2025 Guidance

LifeVantage now expects fiscal 2025 revenue to range between $235 million and $245 million, surpassing its previous guidance of $200 million to $210 million.


CEO Commentary

Steve Fife, President and CEO of LifeVantage, highlighted the key factors driving the company’s exceptional performance:

“Second-quarter revenue results were exceptional, reflecting strong sales of the MindBody GLP-1 System™ launched in October, and our team’s outstanding execution in meeting robust demand. The quarter also saw the highest enrollment figures since Q3 fiscal 2019, showcasing our growing customer base. We are well-positioned for significant growth and shareholder value creation.”

The company plans to release detailed fiscal Q2 results, including profitability outlook, in early February.


About LifeVantage Corporation

LifeVantage Corporation® (Nasdaq: LFVN), established in 2003 and headquartered in Lehi, Utah, is a pioneer in nutrigenomics, focusing on the interaction between nutrition and genes to promote health. The company offers a range of scientifically validated products, including:

  • MindBody GLP-1 System™: A recently launched wellness solution driving strong sales.
  • Protandim® Products: Flagship line for cellular health and oxidative stress management.
  • TrueScience® Liquid Collagen: Skin and beauty enhancer.
  • AXIO® Nootropic Energy Drinks: Mental and physical performance boosters.
  • Petandim®: Formulated to reduce oxidative stress in dogs.

LifeVantage’s business model includes independent consultants who sell products directly to customers while offering entrepreneurial opportunities.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

close